Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN350281

Dynactin 1 (DCTN1) (Internal Region) antibody

Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

DAP-150, DP-150, P135, Chip150, AL022633, Glued, p150, p150, CG9206, DYNA_DROME, Dmel\\CG9206, FCP-D, Glu, P150, P150[Glued], p150/Glued, p150/glued, p150[Glued], p150[glued], t1, Dynactin-1, g ... show more
»Alternatives Internal Region
»Alternatives Human, Mouse (Murine), Rat (Rattus)
»Alternatives Sheep
Clonality Polyclonal
»Alternatives Un-conjugated
»Alternatives Immunohistochemistry (IHC), Western Blotting (WB)
Pubmed 6 references available
Catalog no. ABIN350281
Quantity 100 µL
454.67 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 7 to 8 Business Days
Immunogen A synthetic peptide from the internal region of human DCTN1 (DAP-150, DP-150, p150-glued, p135, Dynactin subunit 1) conjugated to an immunogenic carrier protein was used as the immunogen. The antigen is homologous in rat and moue.
Specificity Appears to be specific for DCTN1.
Purity whole serum
Alternative Name DCTN1 (DAP-150, DP-150, Dynactin subunit 1)
Background Function: Required for the cytoplasmic dynein-driven retrograde movement of vesicles and organelles along microtubules. Dynein-dynactin interaction is a key component of the mechanism of axonal transport of vesicles and organelles.
Subunit: Large macromolecular complex of at least 10 components, p150(glued) binds directly to microtubules and to cytoplasmic dynein. Interacts with the C-terminus of MAPRE1, MAPRE2 and MAPRE3.
Subcellular location: Cytoplasm. Cytoplasm, cytoskeleton.
Tissue specificity: Brain. DISEASE: Defects in DCTN1 are the cause of progressive lower motor neuron disease. PLMND is a progressive dominant disease that has no sensory symptoms. Also known as: DAP-150, DP-150, p150-glued,p135, Dynactin subunit 1, 150 kDa dynein-associated polypeptide.
UniProt Q14203
Application Notes IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Storage -20 °C
Holzbaur, Tokito: "Localization of the DCTN1 gene encoding p150Glued to human chromosome 2p13 by fluorescence in situ hybridization." in: Genomics, Vol. 31, Issue 3, pp. 398-9, 1997 (PubMed).

Tokito, Howland, Lee et al.: "Functionally distinct isoforms of dynactin are expressed in human neurons." in: Molecular biology of the cell, Vol. 7, Issue 8, pp. 1167-80, 1997 (PubMed).

Collin, Nishina, Marshall et al.: "Human DCTN1: genomic structure and evaluation as a candidate for Alström syndrome." in: Genomics, Vol. 53, Issue 3, pp. 359-64, 1998 (PubMed).

Tokito, Holzbaur: "The genomic structure of DCTN1, a candidate gene for limb-girdle muscular dystrophy (LGMD2B)." in: Biochimica et biophysica acta, Vol. 1442, Issue 2-3, pp. 432-6, 1998 (PubMed).

Puls, Jonnakuty, LaMonte et al.: "Mutant dynactin in motor neuron disease." in: Nature genetics, Vol. 33, Issue 4, pp. 455-6, 2003 (PubMed).

Bu, Su: "Characterization of functional domains of human EB1 family proteins." in: The Journal of biological chemistry, Vol. 278, Issue 50, pp. 49721-31, 2003 (PubMed).

Alternatives for antigen "Dynactin 1 (DCTN1)", type "Antibodies"
Hosts (31), (9), (7), (3)
Reactivities (43), (27), (24), (14), (14), (12), (6)
Applications (40), (21), (15), (10), (10), (5), (3), (2), (2), (1), (1)
Conjugates (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Epitopes (19), (6), (5), (3), (1), (1)